Allspring Global Investments
RNAM

Allspring Global Investments’s Avidity Biosciences RNAM Stock Holding History

Allspring Global Investments’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-657
Closed -$30.2K – 2281
2024
Q3 		$30.2K Buy
+657
New +$28.5K ﹤0.01% 1921
2023
Q1 		– Sell
-1,041
Closed -$23.1K – 2916
2022
Q4 		$23.1K Sell
1,041
-23
-2% -$343 ﹤0.01% 2557
2022
Q3 		$17K Sell
1,064
-564
-35% -$10.8K ﹤0.01% 2647
2022
Q2 		$23K Hold
1,628
– – ﹤0.01% 2456
2022
Q1 		$30K Buy
+1,628
New +$27.7K ﹤0.01% 2908

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's RNAM Position: Q4 2024 in Review

Allspring Global Investments sold out of Avidity Biosciences (RNAM) in Q4 2024, closing a stake of 657 shares — an estimated $30.2K sold.

Allspring Global Investments first reported a position in RNAM in Q1 2022 and held it in 5 quarters. The position peaked at $30.2K in Q3 2024. 236 funds tracked by Wall St. Rank hold RNAM as of Q4 2024.

  • Allspring Global Investments reported no remaining Avidity Biosciences position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 657 Avidity Biosciences shares in Q4 2024, an estimated $30.2K.
  • Allspring Global Investments first reported a position in Avidity Biosciences in Q1 2022 and held it in 5 quarters.
  • Allspring Global Investments's Avidity Biosciences position peaked at $30.2K in Q3 2024.
  • 236 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.